Biodesix announces fourth quarter and fiscal year 2024 results

Total revenue of $71.3 million for fy2024, growing 45% over fy2023; gross margins of 78% for fy2024, up 5% points over fy2023 ; fy2025 total revenue guidance of $92-95 million; conference call and webcast today at 4:30 p.m. et louisville, colo.
BDSX Ratings Summary
BDSX Quant Ranking